↓ Skip to main content

American Association for Cancer Research

Cabozantinib Unlocks Efficient In Vivo Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate Tumors

Overview of attention for article published in Molecular Cancer Therapeutics, February 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
22 Mendeley
Title
Cabozantinib Unlocks Efficient In Vivo Targeted Delivery of Neutrophil-Loaded Nanoparticles into Murine Prostate Tumors
Published in
Molecular Cancer Therapeutics, February 2021
DOI 10.1158/1535-7163.mct-20-0167
Pubmed ID
Authors

Kiranj Kishor Chaudagar, Natalie Landon-Brace, Aniruddh Solanki, Hanna M Hieromnimon, Emma Hegermiller, Wen Li, Yue Shao, John Joseph, Devan J Wilkins, Kaela M Bynoe, Xiang-Ling Li, John G Clohessy, Soumya Ullas, Jeffrey M Karp, Akash Patnaik

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 18%
Professor > Associate Professor 3 14%
Student > Ph. D. Student 3 14%
Student > Doctoral Student 1 5%
Lecturer 1 5%
Other 4 18%
Unknown 6 27%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 18%
Engineering 3 14%
Agricultural and Biological Sciences 2 9%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Nursing and Health Professions 1 5%
Other 2 9%
Unknown 9 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2021.
All research outputs
#6,219,324
of 23,267,128 outputs
Outputs from Molecular Cancer Therapeutics
#1,384
of 3,897 outputs
Outputs of similar age
#153,698
of 505,643 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#24
of 71 outputs
Altmetric has tracked 23,267,128 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 3,897 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 505,643 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.